Insider Transactions in Q1 2026 at Arrowhead Pharmaceuticals, Inc. (ARWR)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 06
2026
|
Patrick O'Brien COO |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+12.05%
|
-
|
|
Jan 06
2026
|
Patrick O'Brien COO |
SELL
Bona fide gift
|
Direct |
2,500
-0.11%
|
-
|
|
Jan 06
2026
|
Daniel Joseph Apel Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+29.86%
|
-
|
|
Jan 06
2026
|
James C Hamilton Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+23.3%
|
-
|
|
Jan 05
2026
|
Patrick O'Brien COO |
SELL
Open market or private sale
|
Direct |
49,493
-0.82%
|
$3,118,059
$63.92 P/Share
|
|
Jan 05
2026
|
James C Hamilton Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
40,164
-2.91%
|
$2,570,496
$64.13 P/Share
|
|
Jan 02
2026
|
Christopher Richard Anzalone Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,187
-0.17%
|
$870,342
$66.13 P/Share
|